CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivier, J.-F.
Right arrow Articles by Hemmerling, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olivier, J.-F.
Right arrow Articles by Hemmerling, T.
Canadian Journal of Anesthesia 54:44574 (2007)
© Canadian Anesthesiologists' Society, 2007


Sunday June 24; 1030 - 1230

44574 - PILOT STUDY TO DETERMINE SEVOFLURANE DOSING DURING CARDIO-PULMONARY BYPASS USING BIS MONITORING

Jean-François Olivier1, Julien Rhéaume2, David Bracco3 and Thomas Hemmerling4

1 Montreal General Hospital, Montreal, QC, Canada
2 University of Montreal
3 Montreal General Hospital
4 Montreal General Hospital

Abstract

INTRODUCTION: Volatile anesthetics provide myocardial protection during cardiac surgery. Sevoflurane has gained popularity in cardiac surgery because of its rapid elimination thus allowing fast tracking anesthesia. Titration of sevoflurane dosing during cardiopulmonary bypass (CPB) is important to avoid awareness and provide hemodynamic stability. In this pilot study, we titrated sevoflurane during cardio-pulmonary bypass using bispectral index monitoring (BIS). The aim of this study was to measure the MAC of sevoflurane during normothermic CPB.

METHODS: Local IRB approval was obtained for this study. 20 patients scheduled for elective cardiac surgery using normothermic CPB were enrolled. Anesthesia was induced using propofol 1–1.5 mg/kg, fentanyl 3–5 µg/kg and rocuronium 0.6 mg/kg. Intraoperative analgesia was achieved using high thoracic epidural analgesia with bupivacaine 0.125% at 10 ml/h. Anesthesia was maintained using sevoflurane throughout surgery; during CPB, sevoflurane was administered through the oxygenator to maintain a BIS of 40–55. Exhausted gases from the oxygenator were sampled by an anesthesia gas analyzer. Every min, BIS, the concentration of sevoflurane, blood pressure and central temperature were recorded and averaged by blocks of 5 minutes. Data are presented as means (± SD).

RESULTS: 11 men and 9 women, age 69 ± 12 yrs, were observed during a mean CPB time of 70 ± 26 minutes. Adequate levels of anesthesia could be provided to all patients and no signs of awareness were recorded. Blood pressure was maintained between 60 and 80 mmHg. To maintain BIS between 40 and 60, the mean expired sevoflurane required was 1.36 ± 0.71 % for a mean BIS of 47.5 ± 13.4. There was a negative correlation between BIS and expired Sevoflurane.

DISCUSSION: This is the first study that uses BIS to titrate sevoflurane administration during CPB. Sevoflurane through the oxygenator provides adequate anesthesia during CPB. During normothermic cardiopulmonary bypass, the MAC for sevoflurane is 1.36%.


Figure 1







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Canadian Anesthesiologists' Society.